Analysis of the Max-binding protein MNT in human medulloblastomas

International Journal of Cancer

Volumn 82, Issue 6, 1999, Pages 810-816

  Sommer, Anette ^a   Waha, Anke ^b   Tonn, Jörg ^c   Sörensen, Nils ^c   Hurlin, Peter J ^d   Eisenman, Robert N ^d   Lüscher, Bernhard ^a   Pietsch, Torsten ^b  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BONN   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DNA; MESSENGER RNA; NUCLEAR PROTEIN;

ADOLESCENT; ADULT; ARTICLE; BRAIN TUMOR; CHILD; CHILDHOOD CANCER; CHROMOSOME 17P; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FEMALE; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; TUMOR RECURRENCE; TUMOR SUPPRESSOR GENE;

BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CEREBELLAR NEOPLASMS; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 17; DNA-BINDING PROTEINS; GENES, SUPPRESSOR; GENES, TUMOR SUPPRESSOR; HELIX-LOOP-HELIX MOTIFS; HUMANS; LOSS OF HETEROZYGOSITY; MEDULLOBLASTOMA; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECURRENCE; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032856102     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19990909)82:6<810::AID-IJC7>3.0.CO;2-V     Document Type: Article

References (28)

1. ADESINA, A.M., NALBANTOGLU, J. and CAVENEE, W.K., p53 gene mutation and mdm2 gene amplification are uncommon in medulloblastoma. Cancer Res., 54, 5649-5651 (1994).
2. ALBRECHT, U., ABU-ISSA, R., RATZ, B., HATTORI, M., AOKI, J., ARAI, H., INOUE, K. and EICHELE, G., Platelet-activating factor acetylhydrolase expression and activity suggest a link between neuronal migration and platelet-activating factor. Dev. Biol., 180, 579-593 (1996).
3. BADIALI, M., PESSION, A., BASSO, G., ANDREINI, L., RIGOBELLO, L., GALASSI, E. and GIANGASPERO, F., N-myc and c-myc oncogene amplification in medulloblastomas. Evidence of particularly aggressive behavior of a tumor with c-myc amplification. Tumori, 77, 118-121 (1991).
4. BIGNER, S.H., FRIEDMAN, H.S., VOGELSTEIN, B., OAKES, W.J. and BIGNE, D.D., Amplification of the c-myc gene in human medulloblastoma cell lines and xenografts. Cancer Res., 50, 2347-2350 (1990a). [Erratum published in Cancer Res., 50, 3809 (1990).]
5. BIGNER, S.H., MARK, J. and BIGNER, D.D., Cytogenetics of human brain tumors. Cancer Genet. Cytogenet., 47, 141-154 (1990b).
6. CARROZZO, R. and LEDBETTER, D.H., Dinucleotide repeat polymorphism mapping to the critical region for lissencephaly (17p13.3). Hum. mol. Genet., 2, 615 (1993).
7. HASSIG, C.A., FLEISCHER, T.C., BILLIN, A.N., SCHREIBER, S.L. and AYER, D.E., Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell, 89, 341-347 (1997).
8. HENRIKSSON, M. and LÜSCHER, B., Proteins of the myc network: essential regulators of cell growth and differentiation. Advanc. Cancer Res., 68, 109-182 (1996).
9. HIROTSUNE, S., PACK, S.D., CHONG, S.S., ROBBINS, C.M., PAVAN, W.J., LEDBETTER, D.H. and WYNSHAW-BORIS, A., Genomic organization of the murine Miller-Dieker/lissencephaly region: conservation of linkage with the human region. Genome Res., 7, 625-634 (1997).
10. HURLIN, P.J., QUEVA, C. and EISENMAN, R.N., mnt, a novel max-interacting protein, is coexpressed with myc in proliferating cells and mediates repression at myc binding sites. Genes Dev., 11, 44-58 (1997).
11. KIM, S.K., RO, J.Y., KEMP, B.L., LEE, J.S., KWON, T.J., HONG, W.K. and MAO, L., Identification of two distinct tumor-suppressor loci on the long arm of chromosome 10 in small cell lung cancer. Oncogene, 17, 1749-1753 (1998).
12. KLEIHUES, P., BURGER, P.C. and SCHEITHAUER, B.W., The new WHO classification of brain tumours. Brain Pathol., 3, 255-268 (1993).
13. KOCH, A., TONN, J., ALBRECHT, S., SÖRENSEN, N., WIESTLER, O.D. and PIETSCH, T., Frequent intragenic polymorphism in the 3′ untranslated region of the lissencephaly gene 1 (lis-1). Clin. Genet., 50, 527-528 (1996a).
14. KOCH, A., TONN, J., KRAUS, J.A., SÖRENSEN, N., ALBRECHT, N.S., WIESTLER, O.D. and PIETSCH, T., Molecular analysis of the lissencephaly gene 1 (lis-1) in medulloblastomas. Neuropathol. appl. Neurobiol., 22, 233-242 (1996b).
15. KUCZYK, M.A., SERTH, J., BOKEMEYER, C., SCHWEDE, J., HERRMANN, R., MACHTENS, S., GRUNEWALD, V., HOFNER, K. and JONAS, U., The mxi1 tumor suppressor gene is not mutated in primary prostate cancer. Oncol. Rep., 5, 213-216 (1998).
16. LAHERTY, C.D., YANG, W.-M., SUN, J.-M., DAVIE, J.R., SETO, E. and EISENMAN, R.N., Histone deacetylases associated with the mSin3 corepressor mediate mad transcriptional repression. Cell, 89, 349-356 (1997).
17. LO NIGRO, C., VENESIO, T., REYMOND, A., MERONI, G., ALBERICI, P., CAINARCA, S., ENRICO, F., STACK, M., LEDBETTER, D.H., LISCIA, D.S., BALLABIO, A. and CARROZZO, R., The human rox gene: genomic structure and mutation analysis in human breast tumors. Genomics, 49, 275-282 (1998).
18. MERONI, G. and 12 OTHERS, rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16, 2892-2906 (1997). Addendum: EMBO J., 16, 6055 (1997).
19. MERONI, G. and 12 OTHERS, rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J., 16, 2892-2906 (1997). Addendum: EMBO J., 16, 6055 (1997).
20. PIETSCH, T., SCHARMANN, T., FONATSCH, C., SCHMIDT, D., ÖCKLER, R., FREIHOFF, D., ALBRECHT, S., WIESTLER, O.D., ZELTZER, P. and RIEHM, H., Characterization of five new cell lines derived from human primitive neuroectodermal tumors of the central nervous system. Cancer Res., 54, 3278-3287 (1994).
21. RORKE, L.B., The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors. J. Neuropathol. exp. Neurol., 42, 1-15 (1983).
22. SCHREIBER-AGUS, N., MENG, Y., HOANG, T., HOU, H.J., CHEN, K., GREENBERG, R., CORDON-CARDO, C., LEE, H.W. and DEPINHO, R.A., Role of mxi1 in ageing organ systems and the regulation of normal and neoplastic growth. Nature (Lond.), 393, 483-487 (1998).
23. SOMMER, A., BOUSSET, K., KREMMER, E., AUSTEN, M. and LÜSCHER, B., Identification and characterization of specific DNA-binding complexes containing members of the myc/max/mad network of transcriptional regulators. J. biol. Chem., 273, 6632-6642 (1998).
24. SOMMER, A., HILFENHAUS, S., MENKEL, A., KREMMER, E., SEISER, C., LOIDL, P. and LÜSCHER, B., Cell growth inhibition by the mad/max complex through recruitment of histone deacetylase activity. Curr. Biol., 7, 357-365 (1997).
25. TAKAHASHI, T., KONISHI, H., KOZAKI, K., OSADA, H., SAJI, S., TAKAHASHI, T. and TAKAHASHI, T., Molecular analysis of a myc antagonist, rox/mnt, at 17p13.3 in human lung cancers. Jap. J. Cancer Res., 89, 347-351 (1998).
26. WALES, M.M., BIEL, M.A., EL DEIRY, W., NELKIN, B.D., ISSA, J.-P., CAVENEE, W.K., KUERBITZ, S.J. and BAYLIN, S.B., p53 activates expression of hic-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med., 1, 570-580 (1995).
27. WASSON, J.C., SAYLORS, R.L.D., ZELTZER, P., FRIEDMAN, H.S., BIGNER, S.H., BURGER, P.C., BIGNER, D.D., LOOK, A.T., DOUGLASS, E.C. and BRODEUR, G.M., Oncogene amplification in pediatric brain tumors. Cancer Res., 50, 2987-2990 (1990).
28. WECHSLER, D.S., SHELLY, C.A., PETROFF, C.A. and DANG, C.V., mxi1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells. Cancer Res., 57, 4905-4912 (1997).